{
  "retracted": false,
  "timestamp": 1442793600000,
  "updates": [
    {
      "timestamp": 1586622265978,
      "identifier": {
        "doi": "10.1186/s40064-015-1233-y"
      },
      "type": "correction"
    }
  ],
  "identifier": {
    "doi": "10.1186/s40064-015-0827-8"
  },
  "publisher": "Springer Science and Business Media LLC",
  "title": "Erratum to: Patient costs of breast cancer endocrine therapy agents under Medicare Part D vs with generic formulations"
}
